Immunogenicity and safety of aerosolized measles vaccine: Systematic review and meta-analysis

Vaccine

Volumn 26, Issue 3, 2008, Pages 383-398

  Low, Nicola ^a   Kraemer, Sibylle ^a   Schneider, Martin ^b   Restrepo, Ana Maria Henao ^c  

^a UNIVERSITY OF BERN   (Switzerland)

^b L'Office des Nations Unies a Geneve   (Switzerland)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Aerosols; Immunization; Measles; Measles vaccine

Indexed keywords

MEASLES VACCINE;

AEROSOL; ARTICLE; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; COUGHING; DRUG DOSAGE FORM COMPARISON; DRUG SAFETY; FEVER; HEADACHE; HUMAN; IMMUNOGENICITY; MEASLES; MEASLES VACCINATION; META ANALYSIS; PHOTOPHOBIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SEROCONVERSION; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AEROSOLS; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; HUMANS; IMMUNIZATION; INFANT; MEASLES; MEASLES VACCINE; MEASLES VIRUS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 37549065554     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.11.010     Document Type: Article

References (42)

1. Giudice E.L., and Campbell J.D. Needle-free vaccine delivery. Adv Drug Deliv Rev 58 1 (2006) 68-89
2. Cutts F.T., Clements C.J., and Bennett J.V. Alternative routes of measles immunization: a review. Biologicals 25 3 (1997) 323-338
3. World Health Organization, WHOSIS. WHO Statistical Information System. http://wwwwhoint/whosis/en/indexhtml 2006. Available from: URL: http://www.who.int/whosis/en/index.html.
4. World Health Organization Initiative for Vaccine Research. Acute respiratory infections: measles http://wwwwhoint/vaccine_research/diseases/ari/en/printhtml 2006.
5. Sabin A.B. Immunization against measles by aerosol. Rev Infect Dis 5 3 (1983) 514-523
6. Castro J.F. Measles vaccination by the aerosol method in Mexico. Salud Publica Mex 39 1 (1997) 53-60 [Spanish]
7. Hiremath G.S., and Omer S.B. A meta-analysis of studies comparing the respiratory route with the subcutaneous route of measles vaccine administration. Hum Vaccin 1 1 (2005) 30-36
8. Cohen BJ, Audet S, Andrew N, Beeler J., 2007. Plaque reduction neutralization test for measles antibodies: standardised laboratory method for use in immunogenicity studies of aerosol vaccination. Accepted by Vaccine October, 2007.
9. Amler R.W., Orenstein W.A., and Bart K.J. Aerosolized measles vaccine-will it open the window?. Rev Infect Dis 5 3 (1983) 524-526
10. WHO DoVaB. http://www.who.int/immunization_monitoring/en/globalsummary/scheduleselect.cfm. World Health Organization, Vaccines and Biologicals October 8, 2005. Available from: URL: http://www.who.int/immunization_monitoring/en/globalsummary/scheduleselect.cfm.
11. WHO and UNICEF. Expanded Program of Immunization (EPI). TelMedPAk, Expanded Program in Immunization (EPI) May 11, 2006, http://www.telmedpak.com/homes.asp?a=EPI. Available from: URL: http://www.telmedpak.com/homes.asp?a=EPI.
12. Chalmers I., Adams M., Dickersin K., Hetherington J., Tarnow-Mordi W., Meinert C., et al. A cohort study of summary reports of controlled trials. JAMA 263 10 (1990) 1401-1405
13. National Institute for Clinical Excellence. Guideline development methods: information for National Collaborating Centres and Guideline Developers [February 2004, updated 2005]. http://www.nice.org.uk. London: National Institute for Clinical Excellence; 2006.
14. Higgins J.P., and Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 21 11 (2002) 1539-1558
15. Egger M., Davey S.G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 7109 (1997) 629-634
16. Jacobson R.M. Promises and pitfalls of meta-analysis in vaccine research. Vaccine 17 13-14 (1999) 1628-1634
17. Liashenko V.A., Iuminova N.V., and Krasnova V.P. A non-injection method of using live measles vaccine. Vop Virusol 41 2 (1996) 84-86 [Russian]
18. Fernandez Bracho J.G., and Roldan Fernandez S.G. Early reactions in pupils vaccinated with an aerosol measles vaccine. Salud Publica Mex 32 6 (1990) 653-657 [Spanish]
19. Castro J.F., Bennett J.V., Rincon H.G., Munoz M.T., Sanchez L.A., and Santos J.I. Evaluation of immunogenicity and side effects of triple viral vaccine (MMR) in adults, given by two routes: subcutaneous and respiratory (aerosol). Vaccine 23 8 (2005) 1079-1084
20. Castro J.F. Vaccination against measles. The situation in Mexico and America. Advances in the method of aerosol immunization. Boletin Med Hosp Infantil Mex 47 7 (1990) 449-461 [Spanish]
21. Castro J.F. Diploid cell measles vaccine. JAMA 256 6 (1986) 714
22. Dilraj A., Cutts F.T., Bennett J.V., Fernandez D.C., Cohen B., and Coovadia H.M. Persistence of measles antibody two years after revaccination by aerosol or subcutaneous routes. Pediatr Infect Dis J 19 12 (2000) 1211-1213
23. Dilraj A., Cutts F.T., de Castro J.F., Wheeler J.G., Brown D., Roth C., et al. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomized trial. Lancet 355 9206 (2000) 798-803
24. Bennett J.V., Fernandez D.C., Valdespino-Gomez J.L., Garcia-Garcia M.L., Islas-Romero R., Echaniz-Aviles G., et al. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican school children. Bull World Health Organ 80 10 (2002) 806-812
25. Ekunwe E.O. Immunization by inhalation of aerosolized measles vaccine. Ann Trop Paediatr 10 2 (1990) 145-149
26. Khanum S., Uddin N., Garelick H., Mann G., and Tomkins A. Comparison of Edmonston-Zagreb and Schwarz strains of measles vaccine given by aerosol or subcutaneous injection. Lancet 1 8525 (1987) 150-153
27. Sepulveda-Amor J., Valdespino-Gomez J.L., Garcia-Garcia M.L., Bennett J., Islas-Romero R., Echaniz-Aviles G., et al. A randomized trial demonstrating successful boosting responses following simultaneous aerosols of measles and rubella (MR) vaccines in school age children. Vaccine 20 21-22 (2002) 2790-2795
28. Whittle H.C., Rowland M.G., Mann G.F., Lamb W.H., and Lewis R.A. Immunization of 4-6-month-old Gambian infants with Edmonston-Zagreb measles vaccine. Lancet 2 8407 (1984) 834-837
29. Wong-Chew R.M., Islas-Romero R., Garcia-Garcia M.D., Beeler J.A., Audet S., Santos-Preciado J.I., et al. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to 9-month-old Mexican children. Vaccine 24 5 (2005) 683-690
30. Wong-Chew R.M., Islas-Romero R., Garcia-Garcia M.L., Beeler J.A., Audet S., Santos-Preciado J.I., et al. Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children. J Infect Dis 189 2 (2004) 254-257
31. Sabin A.B., Albrecht P., Takeda A.K., Ribeiro E.M., and Veronesi R. High effectiveness of aerosolized chick embryo fibroblast measles vaccine in 7-month-old and older infants. J Infect Dis 152 6 (1985) 1231-1237
32. Sabin A.B., Flores A.A., Fernandez D.C., Albrecht P., Sever J.L., and Shekarchi I. Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. Part II. Vaccine comparisons and evidence for multiple antibody response. JAMA 251 18 (1984) 2363-2371
33. Sabin A.B., Flores A.A., Fernandez D.C., Sever J.L., Madden D.L., Shekarchi I., et al. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. Part I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines. JAMA 249 19 (1983) 2651-2662
34. Sabin A.B., Fernandez D.C., Flores A.A., Sever J.L., Madden D.L., and Shekarchi I. Clinical trials of inhaled aerosol of human diploid and chick embryo measles vaccine. Lancet 2 8298 (1982) 604
35. Okuno Y., Ueda S., Hosai H., Kitawaki T., Nakamura K., Chiang T.P., et al. Studies on the combined use of killed and live measles vaccines. Part II. Advantages of the inhalation method. Biken J 8 2 (1965) 81-85
36. Torigoe S., Biritwum R.B., Isomura S., Kobune F., Mingle J.A., Toba M., et al. Measles in Ghana: a trial of an alternative means of administration of measles vaccine. J Trop Pediatr 32 6 (1986) 304-359
37. Bellanti J.A., Zeligs B.J., Mendez-Inocencio J., Garcia-Garcia M.L., Islas-Romero R., Omidvar B., et al. Immunologic studies of specific mucosal and systemic immune responses in Mexican school children after booster aerosol or subcutaneous immunization with measles vaccine. Vaccine 22 9-10 (2004) 1214-1220
38. Valdespino Gomez J.L., Zarate Aquino M.L., Dominguez B.E., Solache A.G., and Diaz Ortega J.L. Antimeasles passive natural immunity in infants in Mexico City. Salud Publica Mex 27 6 (1985) 524-531
39. Juni P., Altman D.G., and Egger M. Assessing the quality of randomized controlled trials. In: Egger M., Davey Smith G., and Altman D.G. (Eds). Systematic reviews in health care: meta-analysis in context. 2 Ed. (2001), BMJ Books, London 87-108
40. De Quadros CA. Measles Eradication: experience in the Americas. Morbidity and Mortality Weekly Report, December 31, 1999;48: 57-64.
41. Price D., Jefferson T., and Demicheli V. Methodological issues arising from systematic reviews of the evidence of safety of vaccines. Vaccine 22 15-16 (2004) 2080-2084
42. Harper SA, Fukuda K, Cox NJ, Bridges CB. Advisory Committee on Immunization Practices. Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report September 26, 2003; Recommendations (RR-13): 1-8.